Clinical trial
Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer
NCT00104754 · Alliance for Clinical Trials in Oncology, Other · Withdrawn
Key facts
| NCT number | NCT00104754 |
|---|---|
| Title | Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer |
| Official title | Phase II Trial of Liposome Encapsulated SN38 (LE-SN38) in the Treatment of Small Cell Lung Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | liposomal SN-38 |
| Enrollment | 0 |
| First posted | Mar 4, 2005 |
| Last update posted | Jul 20, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: